2017 American Transplant Congress
eHealth Literacy and Patient Portal Utilization Among Transplant Recipients.
Emory Transplant Center, Atlanta, GA
Background: Healthcare systems are required to engage patients with web-based patient portals. eHealth literacy is a distinct type of health literacy needed to properly understand…2017 American Transplant Congress
Noninvasive Renal Transplant Graft Monitoring in Single Institution Using Cell-Free DNA in Recipient Plasma via Insertion-Deletion Allele Polymorphism.
IntroductionThere is an unmet clinical need in renal transplantation towards early detection of donor organ damage. Serum creatinine(SCr) and biopsies are not ideal.Cell-free donor DNA(cfdDNA)…2017 American Transplant Congress
Clinical Impact of Strength and Class of Pre transplant Donor Specific Antibody on Kidney Transplant Recipient Receiving Steroid Free Maintenance Immunosupression Regimen.
Renal Transplant, Indiana University School of Medicine, Indianapolis, IN
Background: The class and strength of pre- transplant DSA has been described as playing a role in determining future risk of acute rejection (AR) and…2017 American Transplant Congress
Once-Daily versus Twice-Daily Tacrolimus in Living Kidney Transplantation: A Multicenter, Parallel Group, Open-Label, 5-Year, Randomized Non-Inferiority Trial.
Background:Tacrolimus (TAC)-based induction therapy appears to be the standard immunosuppressive regimen for most kidney transplantation recipients (KTRs). TAC is available as a twice-daily (TAC-BID) and…2017 American Transplant Congress
Evolution of CCR4highCD4+ Subpopulations in Renal Graft Blood After Steroid Withdrawal: A Prospective, Randomized, Controlled Study in Parallel Groups. Preliminary Results.
Introduction:Steroids are a mainstay of immunosuppression after kidney transplant (KT). The infiltration into the graft of active T cells following KT depends on the expression…2017 American Transplant Congress
Cardiovascular Disease in Japanese Kidney Transplant Recipients.
Urology, Tokyo Women's Medical University, Tokyo, Japan
BackgroundGlobally, among kidney transplant recipients (KTRs), cardiovascular diseases (CVDs) have been the most frequent cause of death with a preserved transplant kidney function, referred to…2017 American Transplant Congress
mTOR Inhibitor and Low-Dose Tacrolimus in Pediatric Kidney Transplant (PKT): 9-Years Data of a Bi-Therapy Treatment.
Pediatric Nephrology, Hosptal Vall d´Hebron, Barcelona, Spain
INTRODUCTIONNephrotoxicity , serious infectious, or malignancy risk , curtails tacrolimus use in PKT . However, based on potential antiviral and antitumoral actions of mTOR inhibitor…2017 American Transplant Congress
Risk Prediction Models for Living Donor Kidney Transplantation to Predict Donor and Recipient Mortality and Graft Loss.
The purpose of this study was to develop linked risk prediction models for potential donors for and their respective recipients of a kidney transplantation at…2017 American Transplant Congress
Renal Function Variability Is a Significant and Independent Risk Factor for Graft Loss and Death in Kidney Transplantation.
1Transplant, MUSC, Charleston, SC; 2Transplant, Intermountain Healthcare, Salt Lake City, UT
Previous studies have demonstrated that the magnitude of decline in renal function can predict graft loss after kidney transplant (KTX), but there is limited research…2017 American Transplant Congress
Serum Alkaline Phosphatase Predicts Graft Failure and Mortality in Kidney Transplant Recipients.
Objective: Recent studies showed that high levels of serum alkaline phosphatase (ALP) are associated with all-cause or cardiovascular death among hemodialysis patients. However, there are…
- « Previous Page
- 1
- …
- 338
- 339
- 340
- 341
- 342
- …
- 531
- Next Page »